ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Azetidine → {2-Azetidin-1-yl-4-chloro-8-methyl-3-[4-(1H-pyrazol-1-yl)benzyl]quinolin-6-yl}(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methanol

HRID 926637
印刷

反応式

HRID 926637 の反応式
[N:1]1([C:6]2[CH:40]=[CH:39][C:9]([CH2:10][C:11]3[C:12](Cl)=[N:13][C:14]4[C:19]([C:20]=3[Cl:21])=[CH:18][C:17]([C:22]([C:30]3[CH:35]=[CH:34][C:33]([Cl:36])=[CH:32][CH:31]=3)([C:24]3[N:28]([CH3:29])[CH:27]=[N:26][CH:25]=3)[OH:23])=[CH:16][C:15]=4[CH3:37])=[CH:8][CH:7]=2)[CH:5]=[CH:4][CH:3]=[N:2]1.[NH:41]1[CH2:44][CH2:43][CH2:42]1>CN(C=O)C>[N:41]1([C:12]2[C:11]([CH2:10][C:9]3[CH:39]=[CH:40][C:6]([N:1]4[CH:5]=[CH:4][CH:3]=[N:2]4)=[CH:7][CH:8]=3)=[C:20]([Cl:21])[C:19]3[C:14](=[C:15]([CH3:37])[CH:16]=[C:17]([C:22]([C:30]4[CH:31]=[CH:32][C:33]([Cl:36])=[CH:34][CH:35]=4)([C:24]4[N:28]([CH3:29])[CH:27]=[N:26][CH:25]=4)[OH:23])[CH:18]=3)[N:13]=2)[CH2:44][CH2:43][CH2:42]1
参加物反応条件実験手順後処理出典と根拠反応ノート

参加物

4

反応物 2

HCID 10422AzetidineHCID 74221529(3-(4-(1H-Pyrazol-1-yl)benzyl)-2,4-dichloro-8-methylquinolin-6-yl)(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methanol2 回

生成物 1

HCID 118006267{2-Azetidin-1-yl-4-chloro-8-methyl-3-[4-(1H-pyrazol-1-yl)benzyl]quinolin-6-yl}(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methanol

試薬・触媒・溶媒 1

HCID 6228Dimethylformamide溶媒

反応条件

温度
100 °C

実験手順

(3-(4-(1H-Pyrazol-1-yl)benzyl)-2,4-dichloro-8-methylquinolin-6-yl)(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methanol (200 mg, 0.34 mmol, Intermediate 67), azetidine (194 mg, 3.40 mmol), and DMF (2 mL) were combined in a reaction tube, then sealed and heated to 100° C. and maintained at that temperature overnight. The reaction vessel was then cooled to room temperature and the solvent and excess azetidine were removed by reduced pressure distillation. The crude residue was taken up into EtOAc, then extracted twice with a saturated, aqueous NH4Cl solution. The organic phase was separated, dried over MgSO4, filtered and concentrated under reduced pressure. The crude material was purified via reverse phase chromatography using acetonitrile with ammonium hydroxide in water as eluent to afford the title compound. MS (ESI): mass calcd. for C34H30Cl2N6O, 608.2. m/z found, 609.2 [M+H]+. 1H NMR (600 MHz, CDCl3) δ ppm 7.86 (d, J=2.1 Hz, 1H), 7.84 (d, J=2.4 Hz, 1H), 7.66 (d, J=1.7 Hz, 1H), 7.57-7.54 (m, 2H), 7.37 (dd, J=2.3, 1.1 Hz, 1H), 7.32-7.29 (m, 2H), 7.25 (d, J=8.5 Hz, 2H), 7.19-7.15 (m, 2H), 7.13 (s, 1H), 6.43-6.40 (m, 1H), 6.29 (d, J=1.2 Hz, 1H), 5.80-5.74 (m, 1H), 4.27 (s, 2H), 4.11 (t, J=7.5 Hz, 4H), 3.32 (s, 3H), 2.58 (s, 3H), 2.26-2.17 (m, 2H).

後処理

  1. customsealed
  2. temperaturemaintained at that temperature overnight
  3. temperatureThe reaction vessel was then cooled to room temperature
  4. customthe solvent and excess azetidine were removed by reduced pressure distillation
  5. extractionextracted twice with a saturated, aqueous NH4Cl solution
  6. customThe organic phase was separated
  7. dry with materialdried over MgSO4
  8. filtrationfiltered
  9. concentrationconcentrated under reduced pressure
  10. customThe crude material was purified via reverse phase chromatography

出典と根拠

ORDレコード
ord-63fdfb4d69b049e6a6e3d8ff9ce19606
出典データセット
uspto-grants-2016_03
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US09284308B2

反応ノート

このページの内容参加物反応条件実験手順後処理出典と根拠反応ノート